MarketInOut Stock Screener Log In | Sign Up

GlobeStar Therapeutics Corp

OTC • Healthcare • Biotechnology • Quote as of 11/17/2026 09:51
GlobeStar Therapeutics Corp stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization0.1241 mln
Float1,154 mln

Relative Strength

62 / 100
Outperforming

ROE

148
Extraordinary

Business Description

GlobeStar Therapeutics Corporation is a New York-based drug development company focused on bringing new treatment options to patients with multiple sclerosis and other diseases that affect the nervous system. The company holds patents on its drug formulations and is currently working through clinical trials in the United States. It was previously called AngioSoma Inc. before adopting its current name in July 2021.

Key Fundamentals

EPS-0.00
ROE148
ROIC175
Interest Cover-20.35
EBITDA, mln-0.58
EV / EBITDA76.94

Quote Details

Last 0.00001
Change 0.000009 (900%)
Open 0.00001
Volume 101,474
Turnover 1.01
Average Volume 823,978

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 900% 56 / 100   
1 Month -90% 0 / 100   
2 Months 900% 67 / 100   
6 Months -96.67% 1 / 100   
1 Year -99% 0 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog